PDCD1 and mature T-cell and NK-cell non-Hodgkin lymphoma: For T cell lymphoma, anti-PD-1 antibodies have shown modest efficacy in r/r PTCL, but results were limited by a small sample size and concerns of rapid disease progression [26, 27].